Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis
Breast Care · 2022 · 17 (1) · 55-62
DOI: 10.1159/000514419 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Breast Care, online erschienen am 18.02.2021. Verfasst von Huiying Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Periductal mastitis (PDM) is a complex benign breast disease with a prolonged course and a high risk of recurrence after treatment. There are many available treatments for PDM, but none is widely accepted. This study aims to evaluate the various treatment failure rates (TFR) of different invasive treatment measures by looking at recurrence and persistence after treatment. In this way, it sets out to inform better clinical decisions in the treatment of PDM.
Methods
We searched PubMed, Embase, and Cochrane Library databases for eligible studies about different treatment regimens provided to PDM patients that had been published before October 1, 2019. We included original studies written in English that reported the recurrence and/or persistence rates of each therapy. Outcomes were presented as pooled TFR and 95% CI for the TFR.
Results
We included 27 eligible studies involving 1,066 patients in this study. We summarized 4 groups and 10 subgroups of PDM treatments, according to the published studies. Patients treated minimally invasively (group 1) were subdivided into 3 subgroups and pooled TFR were calculated as follows: incision and drainage (n = 73; TFR = 75.6%; 95% CI 27.3–100%), incision alone (n = 74; TFR = 20.1%; 95% CI 0–59.9%), and breast duct irrigation (n = 123; TFR = 19.4%; 95% CI 0–65.0%). Patients treated with a minor excision (excision of the infected tissue and related duct; group 2) were divided into 4 subgroups and pooled TFR were calculated as follows: wound packing alone (n = 127; TFR = 2.1%; 95% CI 0–5.2%), primary closure alone (n = 66; TFR = 37.1%; 95% CI 9.5–64.8%), primary closure under antibiotic treatment cover (n = 55; TFR = 4.8%; 95% CI 0–11.4%) , and additional nipple part removal (n = 232; TFR = 9.6%; 95% CI 5.8–13.4%). Patients treated with a major excision (excision of the infected tissue and the major duct; group 3) included the following 2 subgroups: patients treated with a circumareolar incision (n = 142; TFR = 7.5%; 95% CI 0.4–14.7%) and patients treated with a radial incision of the breast (n = 78; TFR = 0.6%; 95% CI 0–3.6%). Group 4 contained patients receiving different major plastic surgeries. The pooled TFR of this group (n = 86) was 3.4% (95% CI 0–7.5%).
Conclusion
Breast duct irrigation, which is the most minimally invasive of all of the treatment options, seemed to yield good outcomes and may be the first-line treatment for PDM patients. Minor excision methods, except for primary closure alone, might be enough for most PDM patients. Major excision, especially with radial incision, was a highly effective salvage therapy. The major plastic surgery technique was also acceptable as an alternative treatment for patients with large lesions and concerns about breast appearance. Incision and drainage and minor excision with primary closure alone should be avoided for PDM patients. Further research is still needed to better understand the etiology and pathogenesis of PDM and explore more effective treatments for this disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast Center, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, China.
- Breast Surgery, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.
- Department of Breast Disease, Peking University Shougang Hospital, Beijing, China.
Zitieren
APA
Xu, H., Liu, R., Lv, Y., Fan, Z., Mu, W., Yang, Q., Fu, H., & Li, Y. (2022). Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis. Breast Care, 17(1), 55-62. https://doi.org/10.1159/000514419
Vancouver
Xu H, Liu R, Lv Y, Fan Z, Mu W, Yang Q, et al. Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis. Breast Care. 2022;17(1):55-62. doi:10.1159/000514419
BibTeX
@article{Xu2022,
author = {Xu, Huiying and Liu, Ruidong and Lv, Yanli and Fan, Zhenhua and Mu, Weimin and Yang, Qingzhong and Fu, Hui and Li, Yi},
title = {Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis},
journal = {Breast Care},
year = {2022},
volume = {17},
number = {1},
pages = {55--62},
doi = {10.1159/000514419}
}
EUVIMED